The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Clinical Strains of Pseudomonas aeruginosa Overproducing MexAB-OprM and MexXY Efflux Pumps Simultaneously
Open accessAbstract
Simultaneous overexpression of the MexAB-OprM and MexXY efflux systems was demonstrated by real-time reverse transcription-PCR and immunoblotting experiments for 12 multiresistant clinical isolates of Pseudomonas aeruginosa . DNA sequencing analysis showed that nine of these strains (named agrZ mutants) harbored mutations in mexZ , the product of which downregulates the expression of the mexXY operon. In addition, 8 of the 12 strains exhibited mutations in genes known to control transcription of the mexAB-oprM operon. Four of them were nalB mutants with alterations in the repressor gene mexR , three of them appeared to be nalC mutants deficient in gene PA3721 and overexpressing gene PA3720 , and one strain was a nalB nalC double mutant. For MexAB-OprM as well as for MexXY, no clear correlation could be established between (i) the types of mutations, (ii) the expression level of mexA or mexX , and (iii) resistance to effluxed antibiotics. Finally, three isolates, named agrW mutants, overproduced MexXY and had an intact mexZ gene, and four strains overproduced MexAB-OprM and had intact mexR and PA3721 genes ( nalD mutants). These data show that clinical isolates are able to broaden their drug resistance profiles by coexpressing two Mex efflux pumps and suggest the existence of additional regulators for MexAB-OprM and MexXY.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Manual of Clinical Microbiology.
(1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-93-6-939_2 · Cited by 14,411
Pfaffl, M. W. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.9.e36 · Cited by 7,376
Manual of Clinical Microbiology
BALOWS, A., HAUSLER Jr., W. J., HERRMANN, K. L., ISENBERG, H. D., & SHADOMY, H. J. (1991) · Revista do Instituto de Medicina Tropical de São Paulo · doi:10.1590/s0036-46651991000600015 · Cited by 1,131
Masuda, N., Sakagawa, E., Ohya, S., Gotoh, N., Tsujimoto, H., & Nishino, T. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.12.3322-3327.2000 · Cited by 722
The Use of Analytical Isoelectric Focusing for Detection and Identification of -Lactamases
MATTHEW, M., HARRIS, A. M., MARSHALL, M. J., & ROSS, G. W. (1975) · Journal of General Microbiology · doi:10.1099/00221287-88-1-169 · Cited by 688
Poole, K., Krebes, K., McNally, C., & Neshat, S. (1993) · Journal of Bacteriology · doi:10.1128/jb.175.22.7363-7372.1993 · Cited by 688
Role of mexA-mexB-oprM in antibiotic efflux in Pseudomonas aeruginosa
Li, X. Z., Nikaido, H., & Poole, K. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.9.1948 · Cited by 643
Ko¨hler, T., Michéa‐Hamzehpour, M., Henze, U., Gotoh, N., Kocjancic Curty, L., & Pechère, J. (1997) · Molecular Microbiology · doi:10.1046/j.1365-2958.1997.2281594.x · Cited by 549
Poole, K., Gotoh, N., Tsujimoto, H., Zhao, Q., Wada, A., Yamasaki, T., Neshat, S., Yamagishi, J., Li, X., & Nishino, T. (1996) · Molecular Microbiology · doi:10.1046/j.1365-2958.1996.281397.x · Cited by 443
Li, X. Z., Livermore, D. M., & Nikaido, H. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.8.1732 · Cited by 402
Aires, J. R., Köhler, T., Nikaido, H., & Plésiat, P. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.11.2624 · Cited by 391
Self-citationPoole, K., Tetro, K., Zhao, Q., Neshat, S., Heinrichs, D. E., & Bianco, N. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.9.2021 · Cited by 324
Contribution of the MexX-MexY-OprM Efflux System to Intrinsic Resistance in Pseudomonas aeruginosa
Masuda, N., Sakagawa, E., Ohya, S., Gotoh, N., Tsujimoto, H., & Nishino, T. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.9.2242-2246.2000 · Cited by 279
Ziha-Zarifi, I., Llanes, C., Köhler, T., Pechere, J.-C., & Plesiat, P. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.2.287 · Cited by 276
Self-citationExpression in Escherichia coli of a New Multidrug Efflux Pump, MexXY, from Pseudomonas aeruginosa
Mine, T., Morita, Y., Kataoka, A., Mizushima, T., & Tsuchiya, T. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.2.415 · Cited by 274
Lee, A., Mao, W., Warren, M. S., Mistry, A., Hoshino, K., Okumura, R., Ishida, H., & Lomovskaya, O. (2000) · Journal of Bacteriology · doi:10.1128/jb.182.11.3142-3150.2000 · Cited by 263
Westbrock-Wadman, S., Sherman, D. R., Hickey, M. J., Coulter, S. N., Zhu, Y. Q., Warrener, P., Nguyen, L. Y., Shawar, R. M., Folger, K. R., & Stover, C. K. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.12.2975 · Cited by 242
Jalal, S., Ciofu, O., Høiby, N., Gotoh, N., & Wretlind, B. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.3.710-712.2000 · Cited by 236
Chuanchuen, R., Narasaki, C. T., & Schweizer, H. P. (2002) · Journal of Bacteriology · doi:10.1128/jb.184.18.5036-5044.2002 · Cited by 228
Aendekerk, S., Ghysels, B., Cornelis, P., & Baysse, C. (2002) · Microbiology · doi:10.1099/00221287-148-8-2371 · Cited by 212
Carbapenem Resistance Mechanisms in Pseudomonas aeruginosa Clinical Isolates
Pai, H., Kim, J.-W., Kim, J., Lee, J. H., Choe, K. W., & Gotoh, N. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.2.480-484.2001 · Cited by 205
Evans, K., Adewoye, L. O., & Poole, K. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.3.807-812.2001 · Cited by 181
Jellen-Ritter, A., & Kern, W. V. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.5.1467-1472.2001 · Cited by 180
Hocquet, D., Vogne, C., El Garch, F., Vejux, A., Gotoh, N., Lee, A., Lomovskaya, O., & Plésiat, P. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.4.1371-1375.2003 · Cited by 177
Self-citationSrikumar, R., Paul, C. J., & Poole, K. (2000) · Journal of Bacteriology · doi:10.1128/jb.182.5.1410-1414.2000 · Cited by 160
Pseudomonas aeruginosa : infections and treatment
Baltch, A. L., & Smith, R. P. (1994) · Marcel Dekker eBooks · Cited by 159
Köhler, T., Kok, M., Michea-Hamzehpour, M., Plésiat, P., Gotoh, N., Nishino, T., Curty, L. K., & Pechère, J. C. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.10.2288 · Cited by 154
Vogne, C., Aires, J., Bailly, C., Hocquet, D., & Plésiat, P. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.5.1676-1680.2004 · Cited by 141
Self-citationLim, D., Poole, K., & Strynadka, N. C. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111381200 · Cited by 140
Mechanisms of Quinolone Resistance in Clinical Strains of Pseudomonas aeruginosa
Jalal, S., & Wretlind, B. (1998) · Microbial Drug Resistance · doi:10.1089/mdr.1998.4.257 · Cited by 139
Okamoto, K., Gotoh, N., & Nishino, T. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.7.1964-1971.2001 · Cited by 137
A large outbreak of multiresistant Pseudomonas aeruginosa strains in north-eastern Germany
Panzig, B., Schröder, G., Pitten, F. A., & Gründling, M. (1999) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/43.3.415 · Cited by 131
Aminoglycoside Efflux in Pseudomonas aeruginosa : Involvement of Novel Outer Membrane Proteins
Jo, J. T. H., Brinkman, F. S. L., & Hancock, R. E. W. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.3.1101-1111.2003 · Cited by 125
Saito, K., Yoneyama, H., & Nakae, T. (1999) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1999.tb08709.x · Cited by 115
Genetic and Phenotypic Variations of a ResistantPseudomonas aeruginosaEpidemic Clone
Hocquet, D., Bertrand, X., Köhler, T., Talon, D. R., & Plésiat, P. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.6.1887-1894.2003 · Cited by 85
Self-citationMao, W., Warren, M. S., Lee, A. Y., Mistry, A., & Lomovskaya, O. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.7.2001-2007.2001 · Cited by 82
Zhao, Q., Li, X.-Z., Mistry, A., Srikumar, R., Zhang, L., Lomovskaya, O., & Poole, K. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.9.2225 · Cited by 78
Two Efflux Systems Expressed Simultaneously in Multidrug-Resistant Pseudomonas aeruginosa
Pumbwe, L., & Piddock, L. J. V. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.10.2861-2864.2000 · Cited by 72
Crossing the envelope: how cephalosporins reach their targets
Nikaido, H. (2000) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2000.tb02036.x · Cited by 19
Cited by
Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategies
Pang, Z., Raudonis, R., Glick, B. R., Lin, T.-J., & Cheng, Z. (2019) · Biotechnology Advances · doi:10.1016/j.biotechadv.2018.11.013 · Cited by 2,306
Lister, P. D., Wolter, D. J., & Hanson, N. D. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00040-09 · Cited by 1,789
The Challenge of Efflux-Mediated Antibiotic Resistance in Gram-Negative Bacteria
Li, X.-Z., Plésiat, P., & Nikaido, H. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00117-14 · Cited by 1,614
Clinically Relevant Chromosomally Encoded Multidrug Resistance Efflux Pumps in Bacteria
Piddock, L. J. V. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.19.2.382-402.2006 · Cited by 1,231
Efflux-mediated antimicrobial resistance
Poole, K. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki171 · Cited by 1,082
Metadata
- Authors
- Llanes, C., Hocquet, D., Vogne, C., Benali-Baitich, D., Neuwirth, C., & Plésiat, P.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2004-05
- Volume
- 48
- Issue
- 5
- Pages
- 1797-1802
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2123053255
- Cited by
- 277
- References
- 39
- FWCI
- 8.12
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.